Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Earnings Call

Encompass Health Earnings Call: Key Takeaways

Encompass Health delivered a strong Q3 2026 beat and raised full-year guidance, driven by high-acuity patient mix and effective labor cost management despite regulatory headwinds.

Full earnings call on the Alfa Finder USA YouTube channel · Open on YouTube ↗
Highlights
Revenue GrowthQ3 revenue up 8.9%; 5.7% discharge growth; 4% net revenue per discharge.
Mgmt ConfidenceHigh confidence; raising 2026 guidance for revenue, EBITDA, and adjusted EPS.
Demand VisibilityStrong demand; 58 hospitals at >90% occupancy; 20% VA segment growth.
Order BookPipeline of 15 announced hospitals with 654 beds beyond 2026.
Margin TrendsAdjusted EBITDA margin improved; premium labor spend declined $3.9M year-over-year.
Op. LeverageSWB per FTE up 3.8%; contract labor at record low 0.9%.
Pricing PowerNet revenue per discharge up 4% driven by higher patient acuity.
Vol vs PriceGrowth driven by 5.7% volume increase and 4% pricing/acuity improvement.
Segment GrowthStroke patients up 5.1%; Neuro up 9.3%; Major Trauma up 10.3%.
New ClientsVA growth of 21% in Q3; 15 prioritized markets in North Carolina.
Capex & DebtNet leverage 1.8x; $203.7M share repurchases year-to-date; $100M senior notes issued.
RegulatoryRCD expansion to 75 hospitals; Florida Medicaid supplemental payment reversal $9.2M.
CommentaryHub and spoke strategy utilizing new small-format hospitals to address capacity.
New LaunchesNew hospitals in North Town, Bangor, San Antonio; first small-format hospitals planned.

Growth

Revenue grew 8.9% to $6.45-$6.5B guided range; adjusted EBITDA increased 15.5% to $346.6M.

Outlook

Opening 6-10 hospitals annually; 150-200 beds adding in 2027; 15-hospital pipeline with 654 beds.

Risks

System conversion caused bad debt spike to 2.7%; RCD expansion creates administrative uncertainty for 75 hospitals.

Source

The company's earnings call, NYSE: EHC, and its 8-K filed with the SEC. Summary written with AI assistance from the call.

Read the 8-K ↗

Encompass Health Corp: key numbers

Share price
$142.11Close, Nov 16
Market cap
$13.9B
Shares outstanding
98.12MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Services-HospitalsSIC 8060

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Encompass Health Corp

All →
7:36 AM ET 8-K
Business Update

Encompass Health Business Update

Encompass Health announced the indefinite closure of its 90-bed Sea Pines Rehabilitation Hospital in Melbourne, Florida, following catastrophic flooding and patient evacuation on November 1-2, 2026. The company is evaluating options to refurbish or replace the facility with its joint venture partner, Holmes Regional Medical Center. Despite the closure, the company reaffirmed its full-year 2026 financial guidance.

2:43 PM ET 10-Q
Financial Results

Encompass Health Q3 2026 Results: Net Income $150M, Up 18.5% YoY

Encompass Health reported net operating revenues of $1,609.5 million for the third quarter of 2026, a 9% increase over the prior year. Net income attributable to the company rose to $149.9 million, driven by strong performance in continuing operations despite increased operating expenses and share repurchases totaling $204.2 million for the nine-month period.

Key figure
Net income $150M · +18.5% YoY
4:26 PM ET 8-K
Financial Results

Encompass Health Financial Results

Encompass Health reported Q3 2026 net operating revenue of $1.61 billion, an 8.9% increase year-over-year, driven by a 5.7% growth in discharges. The company increased its full-year 2026 guidance for revenue, Adjusted EBITDA, and adjusted EPS following strong performance and the opening of four new hospitals year-to-date.

Term
Q3 2026

“We are very pleased with our performance for the third quarter, with revenue increasing 8.9% and Adjusted EBITDA growing 15.5%. During the first nine months of 2026, we opened four hospitals totaling 189 beds and added 85 beds to existing hospitals, reflecting our commitment to meeting the growing demand for high-quality inpatient rehabilitation services. Our value proposition and disciplined operating strategy continue to be validated, and we remain highly optimistic about the long-term prospects of our business.”

Mark Tarr, President and Chief Executive Officer

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.